Ost-müük Cyclo Therapeutics, Inc. - CYTH CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.41 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | N/A |
Avatud* | N/A |
Aastane muutus* | N/A |
Päeva ulatus* | N/A |
52 nädala ulatus | 0.67-2.75 |
Keskmine maht (10 päeva) | 74.33K |
Keskmine maht (3 kuud) | 2.95M |
Turukapitalisatsioon | 20.78M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 15.31M |
Tulu | 1.38M |
EPS | -1.83 |
Dividendid (% kasumist) | N/A |
Beeta | -0.41 |
Järgmine tuluaruande kuupäev | Aug 14, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Jun 27, 2022 | 1.93 | -0.01 | -0.52% | 1.94 | 1.94 | 1.93 |
May 23, 2022 | 1.91 | 0.00 | 0.00% | 1.91 | 1.91 | 1.91 |
Mar 28, 2022 | 2.39 | -0.01 | -0.42% | 2.40 | 2.40 | 2.39 |
Feb 24, 2022 | 2.78 | 0.00 | 0.00% | 2.78 | 2.78 | 2.78 |
Feb 11, 2022 | 3.36 | -0.38 | -10.16% | 3.74 | 3.74 | 3.28 |
Feb 10, 2022 | 3.69 | 0.15 | 4.24% | 3.54 | 3.93 | 3.54 |
Feb 9, 2022 | 3.72 | 0.20 | 5.68% | 3.52 | 3.81 | 3.52 |
Feb 8, 2022 | 3.62 | 0.19 | 5.54% | 3.43 | 3.64 | 3.43 |
Feb 7, 2022 | 3.57 | 0.00 | 0.00% | 3.57 | 3.59 | 3.23 |
Feb 4, 2022 | 3.49 | 0.06 | 1.75% | 3.43 | 3.64 | 3.09 |
Feb 3, 2022 | 3.44 | -0.19 | -5.23% | 3.63 | 3.73 | 3.31 |
Feb 2, 2022 | 3.56 | -0.19 | -5.07% | 3.75 | 3.77 | 3.48 |
Feb 1, 2022 | 3.79 | -0.03 | -0.79% | 3.82 | 3.84 | 3.52 |
Jan 31, 2022 | 3.66 | 0.05 | 1.39% | 3.61 | 3.71 | 3.51 |
Jan 28, 2022 | 3.57 | 0.04 | 1.13% | 3.53 | 3.63 | 3.46 |
Jan 27, 2022 | 3.52 | -0.14 | -3.83% | 3.66 | 3.71 | 3.46 |
Jan 26, 2022 | 3.74 | 0.01 | 0.27% | 3.73 | 3.95 | 3.66 |
Jan 25, 2022 | 3.77 | 0.19 | 5.31% | 3.58 | 3.95 | 3.58 |
Jan 24, 2022 | 3.57 | -0.10 | -2.72% | 3.67 | 3.79 | 3.38 |
Jan 21, 2022 | 3.76 | -0.14 | -3.59% | 3.90 | 3.90 | 3.68 |
Cyclo Therapeutics, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
Monday, August 14, 2023 | ||
Kellaaeg (UTC) (UTC) 20:00 | Riik US
| Sündmus Q2 2023 Cyclo Therapeutics Inc Earnings Release Q2 2023 Cyclo Therapeutics Inc Earnings ReleaseForecast -Previous - |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 1.37576 | 1.58576 | 0.90338 | 1.0072 | 1.01148 |
Tulu | 1.37576 | 1.58576 | 0.90338 | 1.0072 | 1.01148 |
Kulud, Kokku | 0.14995 | 0.16679 | 0.07359 | 0.08379 | 0.10885 |
Brutokasum | 1.22581 | 1.41897 | 0.82979 | 0.92341 | 0.90263 |
Kogu tegevuskulu | 16.8391 | 15.8758 | 9.86478 | 8.55176 | 5.27828 |
Müük/Üldine/admin kulud, kokku | 7.82867 | 6.53842 | 3.68199 | 3.43936 | 2.43589 |
Uuringud ja arendus | 8.99954 | 9.15378 | 6.09645 | 4.86916 | 2.71128 |
Depreciation / Amortization | 0.01948 | 0.01683 | 0.01276 | 0.00568 | 0.01012 |
Ootamatud kulutused (tulu) | -0.15852 | 0 | 0.15377 | 0.01215 | |
Tulud majandustegevusest | -15.4634 | -14.2901 | -8.9614 | -7.54456 | -4.2668 |
Intressitulud (kulu), muud tulud, neto | 0.01247 | 0.00341 | 0.0198 | 0.01203 | 0.01177 |
Netotulu enne makse | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Netotulu pärast makse | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Netotulu enne erikulusid | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Netotulu | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Arvestatav tulu, v a erikulud | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Arvestatav tulu, koos erikuludega | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Jaotamisele kuuluv netotulu | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Keskmine jaotamisele kuuluv aktsia kohta | 8.43918 | 6.37007 | 1.59922 | 1.08192 | 0.81757 |
Jaotatav EPS, v a erakorralised kulud | -1.83085 | -2.24278 | -5.59122 | -6.96221 | -5.2045 |
Jaotamisele kuuluv normaal-EPS | -1.84964 | -2.24278 | -5.59122 | -6.82008 | -5.18964 |
Erakorralised kulud kokku | 0 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kogutulu | 0.1868 | 0.45217 | 0.54189 | 0.1949 | 0.58512 |
Tulu | 0.1868 | 0.45217 | 0.54189 | 0.1949 | 0.58512 |
Kulud, Kokku | 0.01661 | 0.03521 | 0.07734 | 0.02079 | 0.07363 |
Brutokasum | 0.17019 | 0.41696 | 0.46455 | 0.17411 | 0.51149 |
Kogu tegevuskulu | 5.16971 | 4.70067 | 3.99791 | 2.97084 | 3.37843 |
Müük/Üldine/admin kulud, kokku | 1.96328 | 1.80417 | 2.04144 | 2.01978 | 1.8862 |
Uuringud ja arendus | 3.18495 | 2.85616 | 1.87438 | 1.08405 | 1.4144 |
Depreciation / Amortization | 0.00487 | 0.00513 | 0.00474 | 0.00474 | 0.00421 |
Tulud majandustegevusest | -4.98291 | -4.2485 | -3.45602 | -2.77594 | -2.79331 |
Intressitulud (kulu), muud tulud, neto | 0.00248 | 0.00162 | 0.00403 | 0.00434 | 0.00093 |
Netotulu enne makse | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Netotulu pärast makse | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Netotulu enne erikulusid | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Netotulu | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Arvestatav tulu, v a erikulud | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Arvestatav tulu, koos erikuludega | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Jaotamisele kuuluv netotulu | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Keskmine jaotamisele kuuluv aktsia kohta | 8.47249 | 8.44763 | 8.4179 | 8.4118 | 7.35872 |
Jaotatav EPS, v a erakorralised kulud | -0.58784 | -0.50273 | -0.41008 | -0.32949 | -0.37947 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Jaotamisele kuuluv normaal-EPS | -0.58784 | -0.50273 | -0.41008 | -0.34833 | -0.37947 |
Ootamatud kulutused (tulu) | 0 | 0 | 0 | -0.15852 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Käibevarad kokku | 4.15856 | 19.4363 | 14.0502 | 3.95807 | 2.76961 |
Raha ja lühiajalised investeeringud | 1.54342 | 16.6127 | 12.8461 | 2.78372 | 2.21741 |
Raha ja ekvivalendid | 1.54342 | 16.6127 | 12.8461 | 2.78372 | 2.21741 |
Laekumata arved, neto | 0.05499 | 0.53909 | 0.11179 | 0.18249 | 0.11748 |
Accounts Receivable - Trade, Net | 0.05499 | 0.49311 | 0.07102 | 0.14343 | 0.08004 |
Total Inventory | 0.25449 | 0.22744 | 0.23791 | 0.24263 | 0.41653 |
Prepaid Expenses | 2.30566 | 2.0571 | 0.85443 | 0.74923 | 0.01819 |
Total Assets | 4.21521 | 19.5208 | 14.188 | 4.11323 | 2.91786 |
Property/Plant/Equipment, Total - Net | 0.05666 | 0.07722 | 0.08792 | 0.06456 | 0.01857 |
Note Receivable - Long Term | 0 | 0.00728 | 0.04981 | 0.0906 | 0.12967 |
Other Long Term Assets, Total | |||||
Total Current Liabilities | 3.48067 | 3.83094 | 3.67255 | 3.14112 | 1.92533 |
Payable/Accrued | 3.48067 | 3.67798 | 3.54104 | 3.12474 | 1.92533 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.13371 | 0.11403 | ||
Total Liabilities | 3.48067 | 3.84897 | 3.73548 | 3.17725 | 1.92533 |
Total Long Term Debt | 0 | 0.01803 | 0.0445 | 0 | 0 |
Total Equity | 0.73454 | 15.6719 | 10.4525 | 0.93598 | 0.99252 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Common Stock | 0.00085 | 0.00084 | 0.00048 | 0.01216 | 0.00908 |
Additional Paid-In Capital | 64.5331 | 64.0195 | 44.5138 | 26.0441 | 18.7012 |
Retained Earnings (Accumulated Deficit) | -63.7994 | -48.3485 | -34.0618 | -25.1202 | -17.5877 |
Total Liabilities & Shareholders’ Equity | 4.21521 | 19.5208 | 14.188 | 4.11323 | 2.91786 |
Total Common Shares Outstanding | 8.48185 | 8.40387 | 4.77076 | 1.21565 | 0.90759 |
Total Preferred Shares Outstanding | 0 | 0 | |||
Other Equity, Total | -0.13006 | ||||
Property/Plant/Equipment, Total - Gross | 0.1582 | 0.15928 | 0.15315 | 0.11703 | |
Accumulated Depreciation, Total | -0.10154 | -0.08206 | -0.06523 | -0.05247 | |
Accrued Expenses | 0 | 0.01925 | 0.01748 | 0.01639 | |
Other Liabilities, Total | 0 | 0.01843 | 0.03613 | ||
Long Term Debt | 0 | 0.01803 | 0.0445 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 4.15856 | 8.4218 | 11.777 | 15.8502 | 19.4363 |
Raha ja lühiajalised investeeringud | 1.54342 | 4.2902 | 7.45339 | 11.7986 | 16.6127 |
Raha ja ekvivalendid | 1.54342 | 4.2902 | 7.45339 | 11.7986 | 16.6127 |
Laekumata arved, neto | 0.05499 | 0.39457 | 0.43869 | 0.15772 | 0.53909 |
Accounts Receivable - Trade, Net | 0.05499 | 0.39457 | 0.40993 | 0.11838 | 0.49311 |
Total Inventory | 0.25449 | 0.27114 | 0.26061 | 0.22106 | 0.22744 |
Prepaid Expenses | 2.30566 | 3.46589 | 3.62434 | 3.6729 | 2.0571 |
Total Assets | 4.21521 | 8.48752 | 11.8418 | 15.9242 | 19.5208 |
Property/Plant/Equipment, Total - Net | 0.05666 | 0.06573 | 0.06478 | 0.07393 | 0.07722 |
Note Receivable - Long Term | 0 | 0 | 0 | 0 | 0.00728 |
Total Current Liabilities | 3.48067 | 2.87506 | 2.10177 | 2.87614 | 3.83094 |
Payable/Accrued | 3.48067 | 2.87009 | 2.09197 | 2.86158 | 3.67798 |
Accrued Expenses | 0 | 0.00498 | 0.00981 | 0.01456 | 0.01925 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 0 | 0.13371 |
Total Liabilities | 3.48067 | 2.87506 | 2.10177 | 2.87614 | 3.84897 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0.01803 |
Long Term Debt | 0 | 0 | 0 | 0 | 0.01803 |
Other Liabilities, Total | 0 | ||||
Total Equity | 0.73454 | 5.61246 | 9.74004 | 13.048 | 15.6719 |
Common Stock | 0.00085 | 0.00085 | 0.00084 | 0.00084 | 0.00084 |
Additional Paid-In Capital | 64.5331 | 64.4306 | 64.3113 | 64.1673 | 64.0195 |
Retained Earnings (Accumulated Deficit) | -63.7994 | -58.819 | -54.5721 | -51.1201 | -48.3485 |
Total Liabilities & Shareholders’ Equity | 4.21521 | 8.48752 | 11.8418 | 15.9242 | 19.5208 |
Total Common Shares Outstanding | 8.48185 | 8.45545 | 8.43944 | 8.4152 | 8.40387 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Raha majandustegevusest | -15.1142 | -15.0053 | -8.54019 | -6.58949 | -3.18844 |
Raha majandustegevusest | 0.01948 | 0.01683 | 0.01276 | 0.00568 | 0.01012 |
Deferred Taxes | |||||
Mittelikviidsed varad | 0.36532 | 0.4928 | 0.27131 | 0.44996 | 0.09557 |
Cash Taxes Paid | 0 | 0 | |||
Makstud intressid | 0 | 0.00353 | 0.00053 | 0 | 0 |
Muutused tööjõus | -0.04815 | -1.22827 | 0.11735 | 0.4874 | 0.9609 |
Tulu investeeringutelt | 0.03817 | 0.01482 | -0.01405 | 0.03613 | 0.03294 |
Kapitalikulutused | -0.01509 | -0.0225 | -0.05313 | -0.00132 | -0.00296 |
Muud rahavood investeeringutelt, kokku | 0.05326 | 0.03732 | 0.03908 | 0.03746 | 0.0359 |
Rahavood investeeringutelt | 0.00678 | 18.7571 | 18.6166 | 7.11966 | 4.10194 |
Aktsiate emiteerimine (tagasiost), neto | 18.7638 | 18.4581 | 6.9896 | 4.10194 | |
Laenu väljastamine (kustutamine), neto | 0.00678 | -0.00678 | 0.15852 | ||
Rahaline kogumuutus | -15.0693 | 3.7666 | 10.0624 | 0.56631 | 0.94644 |
Rahavoogudesse investeerimine | 0 | 0.13006 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.4509 | -10.4705 | -6.22358 | -2.77159 | -14.2867 |
Cash From Operating Activities | -15.1142 | -12.3675 | -9.18599 | -4.83025 | -15.0053 |
Cash From Operating Activities | 0.01948 | 0.01461 | 0.00948 | 0.00474 | 0.01683 |
Non-Cash Items | 0.36532 | 0.23078 | 0.13324 | -0.01078 | 0.4928 |
Cash Taxes Paid | |||||
Cash Interest Paid | 0 | 0 | 0 | 0 | 0.00353 |
Changes in Working Capital | -0.04815 | -2.14239 | -3.10513 | -2.05262 | -1.22827 |
Cash From Investing Activities | 0.03817 | 0.03817 | 0.01989 | 0.00932 | 0.01482 |
Capital Expenditures | -0.01509 | -0.01509 | -0.0046 | -0.0046 | -0.0225 |
Other Investing Cash Flow Items, Total | 0.05326 | 0.05326 | 0.02449 | 0.01392 | 0.03732 |
Cash From Financing Activities | 0.00678 | 0.00678 | 0.00678 | 0.00678 | 18.7571 |
Issuance (Retirement) of Stock, Net | 0 | 18.7638 | |||
Net Change in Cash | -15.0693 | -12.3225 | -9.15932 | -4.81416 | 3.7666 |
Issuance (Retirement) of Debt, Net | 0.00678 | 0.00678 | 0.00678 | 0.00678 | -0.00678 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Rafael Holdings Inc | Corporation | 16.5803 | 2514970 | 2514970 | 2023-05-02 | |
Novit, L.P. | Corporation | 6.2641 | 950156 | 950156 | 2023-04-28 | |
Armistice Capital LLC | Hedge Fund | 3.9754 | 603000 | -356940 | 2023-03-31 | HIGH |
Fine (Nathan Scott) | Individual Investor | 2.9298 | 444402 | 299402 | 2023-04-28 | LOW |
Strattan (C E Rick) | Individual Investor | 2.2864 | 346805 | 21360 | 2023-05-17 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.6738 | 253882 | 0 | 2023-03-31 | LOW |
Ostronic Francis Patrick | Individual Investor | 1.642 | 249071 | 26700 | 2023-05-17 | LOW |
Sieger (Markus) | Individual Investor | 1.345 | 204013 | 42962 | 2023-05-17 | LOW |
Shanahan (William S) | Individual Investor | 0.591 | 89648 | 25971 | 2023-05-17 | |
Toig Randall M | Individual Investor | 0.526 | 79781 | 23059 | 2023-05-17 | LOW |
Tate (Jeffrey L) | Individual Investor | 0.4094 | 62101 | 29941 | 2023-04-28 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3445 | 52253 | 0 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1866 | 28300 | 0 | 2023-03-31 | LOW |
Lisjak (Michael Eric) | Individual Investor | 0.124 | 18809 | 6409 | 2023-04-28 | |
Citadel Advisors LLC | Hedge Fund | 0.122 | 18501 | 18501 | 2023-03-31 | HIGH |
Kjems (Lise Lund) | Individual Investor | 0.1124 | 17053 | 0 | 2023-01-25 | |
Tower Research Capital LLC | Hedge Fund | 0.0788 | 11953 | 7168 | 2023-03-31 | HIGH |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.0656 | 9953 | 0 | 2023-01-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.0148 | 2249 | 0 | 2023-03-31 | LOW |
Clear Street Markets LLC | Research Firm | 0.0114 | 1725 | 1725 | 2023-03-31 | HIGH |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Cyclo Therapeutics, Inc. Company profile
Ettevõttest Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc. on kliinilises staadiumis biotehnoloogiaettevõte, mis arendab tsüklodekstriinil põhinevaid tooteid haiguste raviks. Ettevõtte peamine ravimikandidaat Trappsol Cyclo (hüdroksüpropüülbeeta-tsüklodekstriin) on mõeldud Niemann-Picki C-tüüpi haiguse (NPC) raviks. NPC on haruldane ja surmaga lõppev kolesterooli ainevahetuse haigus, mis mõjutab aju, kopse, maksa, põrna ja teisi organeid. Samuti keskendutakse tsüklodekstriinide kasutamisele Alzheimeri tõve ravis. Ettevõtte tootesarjade hulka kuuluvad Trappsol ja Aquaplex. Ettevõte müüb oma keemiatooteid otse klientidele farmaatsia-, diagnostika- ja tööstuskemiatööstuses ning keemiatoodete turustajatele. Ettevõte müüb ka tsüklodekstriine ja nendega seotud tooteid farmaatsia-, toitumis- ja muudele tööstusharudele, peamiselt kasutamiseks diagnostikas ja eriravimites.
Industry: | Pharmaceuticals (NEC) |
6714 Nw 16Th Street,
Suite B
GAINESVILLE
FLORIDA 32653
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com